JPWO2024070504A1 - - Google Patents

Info

Publication number
JPWO2024070504A1
JPWO2024070504A1 JP2024513115A JP2024513115A JPWO2024070504A1 JP WO2024070504 A1 JPWO2024070504 A1 JP WO2024070504A1 JP 2024513115 A JP2024513115 A JP 2024513115A JP 2024513115 A JP2024513115 A JP 2024513115A JP WO2024070504 A1 JPWO2024070504 A1 JP WO2024070504A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024513115A
Other languages
Japanese (ja)
Other versions
JPWO2024070504A5 (https=
JP7586593B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2024070504A1 publication Critical patent/JPWO2024070504A1/ja
Publication of JPWO2024070504A5 publication Critical patent/JPWO2024070504A5/ja
Application granted granted Critical
Publication of JP7586593B2 publication Critical patent/JP7586593B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2024513115A 2022-09-29 2023-09-01 血液保存用組成物及び血液採取容器 Active JP7586593B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022156247 2022-09-29
JP2022156247 2022-09-29
PCT/JP2023/032121 WO2024070504A1 (ja) 2022-09-29 2023-09-01 血液保存用組成物及び血液採取容器

Publications (3)

Publication Number Publication Date
JPWO2024070504A1 true JPWO2024070504A1 (https=) 2024-04-04
JPWO2024070504A5 JPWO2024070504A5 (https=) 2024-09-05
JP7586593B2 JP7586593B2 (ja) 2024-11-19

Family

ID=90477227

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024513115A Active JP7586593B2 (ja) 2022-09-29 2023-09-01 血液保存用組成物及び血液採取容器

Country Status (2)

Country Link
JP (1) JP7586593B2 (https=)
WO (1) WO2024070504A1 (https=)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014528719A (ja) * 2011-09-26 2014-10-30 プレアナリティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング 細胞外核酸の安定化および単離
JP2016518827A (ja) * 2013-03-18 2016-06-30 キアゲン ゲーエムベーハー 細胞外核酸の安定化および単離
WO2017201612A1 (en) * 2016-05-27 2017-11-30 Norgen Biotek Corp. Preservation of cell-free nucleic acids in biological samples
CN109750087A (zh) * 2019-03-05 2019-05-14 温州广立生物医药科技有限公司 一种血液cfDNA提取试剂盒
WO2020132747A1 (en) * 2018-12-24 2020-07-02 Deltadna Biosciences Inc Composition and method for segregating extracellular dna in blood
CN112359091A (zh) * 2020-10-12 2021-02-12 华南理工大学 一种全血游离dna保存剂、真空采血管及其制备方法
WO2021142375A1 (en) * 2020-01-10 2021-07-15 Sio2 Medical Products, Inc. Nucleic acid and cell preservative compositions and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230090675A1 (en) * 2020-03-11 2023-03-23 Sekisui Medical Co., Ltd. Leukocyte concentration separation device, blood collection container, and method for separating leukocytes
JP7169608B1 (ja) * 2022-01-28 2022-11-11 積水メディカル株式会社 血液採取容器、血漿の分離方法、細胞外遊離核酸の分離方法及び細胞外小胞の分離方法
CN118284808A (zh) * 2022-03-25 2024-07-02 积水医疗株式会社 循环肿瘤细胞分离试剂盒、循环肿瘤细胞分离容器及循环肿瘤细胞的分离方法

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014528719A (ja) * 2011-09-26 2014-10-30 プレアナリティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング 細胞外核酸の安定化および単離
JP2016518827A (ja) * 2013-03-18 2016-06-30 キアゲン ゲーエムベーハー 細胞外核酸の安定化および単離
WO2017201612A1 (en) * 2016-05-27 2017-11-30 Norgen Biotek Corp. Preservation of cell-free nucleic acids in biological samples
WO2020132747A1 (en) * 2018-12-24 2020-07-02 Deltadna Biosciences Inc Composition and method for segregating extracellular dna in blood
CN109750087A (zh) * 2019-03-05 2019-05-14 温州广立生物医药科技有限公司 一种血液cfDNA提取试剂盒
WO2021142375A1 (en) * 2020-01-10 2021-07-15 Sio2 Medical Products, Inc. Nucleic acid and cell preservative compositions and methods of use
CN112359091A (zh) * 2020-10-12 2021-02-12 华南理工大学 一种全血游离dna保存剂、真空采血管及其制备方法

Also Published As

Publication number Publication date
WO2024070504A1 (ja) 2024-04-04
JP7586593B2 (ja) 2024-11-19

Similar Documents

Publication Publication Date Title
JPWO2023145137A1 (https=)
JPWO2023181468A1 (https=)
JPWO2024204675A1 (https=)
JPWO2024070504A1 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BY13163U (https=)
BY13160U (https=)
CN307049194S (https=)
CN307047636S (https=)
CN307047590S (https=)
CN307047364S (https=)
CN307049749S (https=)
CN307045199S (https=)
CN307045081S (https=)
CN307044847S (https=)
CN307044755S (https=)
CN307044413S (https=)
CN307050009S (https=)
BY13168U (https=)
BY13166U (https=)
BY13135U (https=)
BY13164U (https=)
CN307050310S (https=)
CN307047478S (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240226

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240226

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20240226

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240402

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240514

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240710

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241008

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241101

R150 Certificate of patent or registration of utility model

Ref document number: 7586593

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150